Anne Y. Saiki

4.9k total citations
19 papers, 528 citations indexed

About

Anne Y. Saiki is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Anne Y. Saiki has authored 19 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Anne Y. Saiki's work include Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Anne Y. Saiki is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Anne Y. Saiki collaborates with scholars based in United States. Anne Y. Saiki's co-authors include Jonathan D. Oliner, Sean Caenepeel, Claude G. Lerner, Jude Canon, Dongyin Yu, Tao Osgood, Steven H. Olson, Qiuping Ye, John L. Baranowski and Linus L. Shen and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anne Y. Saiki

17 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Y. Saiki United States 10 337 282 89 65 49 19 528
Young‐Choon Moon United States 10 451 1.3× 235 0.8× 140 1.6× 48 0.7× 84 1.7× 23 661
Florine Obrist France 14 449 1.3× 335 1.2× 145 1.6× 57 0.9× 27 0.6× 16 842
Isao Kinoyama Japan 11 602 1.8× 288 1.0× 72 0.8× 110 1.7× 58 1.2× 16 826
Taro Semba Japan 10 279 0.8× 271 1.0× 113 1.3× 103 1.6× 52 1.1× 28 594
Ioannis F. Voutsas Greece 16 305 0.9× 305 1.1× 69 0.8× 58 0.9× 24 0.5× 36 812
Carol F. Franks United States 8 425 1.3× 209 0.7× 144 1.6× 33 0.5× 73 1.5× 10 640
Luis A. Carvajal United States 10 550 1.6× 354 1.3× 134 1.5× 49 0.8× 40 0.8× 29 814
Chudi Ndubaku United States 12 500 1.5× 282 1.0× 87 1.0× 32 0.5× 116 2.4× 22 932
Enrique Álvarez United States 9 235 0.7× 196 0.7× 68 0.8× 64 1.0× 17 0.3× 13 401
Lois Resnick‐Silverman United States 15 518 1.5× 311 1.1× 97 1.1× 87 1.3× 27 0.6× 18 728

Countries citing papers authored by Anne Y. Saiki

Since Specialization
Citations

This map shows the geographic impact of Anne Y. Saiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Y. Saiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Y. Saiki more than expected).

Fields of papers citing papers by Anne Y. Saiki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Y. Saiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Y. Saiki. The network helps show where Anne Y. Saiki may publish in the future.

Co-authorship network of co-authors of Anne Y. Saiki

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Y. Saiki. A scholar is included among the top collaborators of Anne Y. Saiki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Y. Saiki. Anne Y. Saiki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lanman, Brian A., Ryan P. Wurz, Rati Verma, et al.. (2025). Abstract ND01: AMG 410: An H/NRAS-sparing pan-KRAS inhibitor with dual GTP(on)/GDP(off)-state activity for the treatment of diverse KRAS-mutant tumors. Cancer Research. 85(8_Supplement_2). ND01–ND01.
2.
Li, Chendi, Qian Qin, Mohammed U. Syed, et al.. (2023). Abstract 3867: Chromatin modification driving sub-clonal resistance to KRAS G12C combination therapies in KRAS mutant non-small cell lung cancer. Cancer Research. 83(7_Supplement). 3867–3867.
3.
Saiki, Anne Y., Deanna Mohn, Yu Li, et al.. (2021). Abstract 1285: In vitro characterization of sotorasib and other RAS ‘His95-groove' binders and investigation of resistance mechanisms. Cancer Research. 81(13_Supplement). 1285–1285. 3 indexed citations
4.
5.
Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. 4484–4484. 1 indexed citations
6.
Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. Cancer Research. 79(13_Supplement). 4484–4484. 13 indexed citations
7.
Rex, Karen, Anne Y. Saiki, Ji-Rong Sun, et al.. (2019). Abstract 3090: In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models. Cancer Research. 79(13_Supplement). 3090–3090. 6 indexed citations
8.
Lanman, Brian A., Jian Jeffrey Chen, Longbin Liu, et al.. (2019). Abstract 4455: Discovery of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of solid tumors. Cancer Research. 79(13_Supplement). 4455–4455. 7 indexed citations
9.
Oliner, Jonathan D., Anne Y. Saiki, & Sean Caenepeel. (2016). The Role of MDM2 Amplification and Overexpression in Tumorigenesis. Cold Spring Harbor Perspectives in Medicine. 6(6). a026336–a026336. 177 indexed citations
10.
Canon, Jude, Tao Osgood, Anne Y. Saiki, & Jonathan D. Oliner. (2016). Abstract 3761: The MDM2 inhibitor AMG 232 causes tumor regression and potentiates the anti-tumor activity of MEK inhibition and DNA-damaging cytotoxic agents in preclinical models of acute myeloid leukemia. Cancer Research. 76(14_Supplement). 3761–3761. 3 indexed citations
11.
Canon, Jude, Tao Osgood, Steven H. Olson, et al.. (2015). The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents. Molecular Cancer Therapeutics. 14(3). 649–658. 116 indexed citations
12.
Saiki, Anne Y., Sean Caenepeel, Elissa J. Cosgrove, et al.. (2015). Identifying the determinants of response to MDM2 inhibition. Oncotarget. 6(10). 7701–7712. 32 indexed citations
13.
Saiki, Anne Y., Sean Caenepeel, Dongyin Yu, et al.. (2014). MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways. Oncotarget. 5(8). 2030–2043. 45 indexed citations
14.
Beck, Hilary P., Brian M. Fox, John G. Allen, et al.. (2010). Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2752–2755. 29 indexed citations
15.
Pratt, Steven, Peter J. Dandliker, Xiaoling Xuei, et al.. (2004). A Strategy for Discovery of Novel Broad-Spectrum Antibacterials Using a High-Throughput Streptococcus pneumoniae Transcription/Translation Screen. SLAS DISCOVERY. 9(1). 3–11. 22 indexed citations
16.
Yu, Liping, J. Mack, Philip J. Hajduk, et al.. (2003). Solution structure and function of an essential CMP kinase of Streptococcus pneumoniae. Protein Science. 12(11). 2613–2621. 18 indexed citations
17.
Saiki, Anne Y., Linus L. Shen, Chih‐Ming Chen, John L. Baranowski, & Claude G. Lerner. (1999). DNA Cleavage Activities of Staphylococcus aureus Gyrase and Topoisomerase IV Stimulated by Quinolones and 2-Pyridones. Antimicrobial Agents and Chemotherapy. 43(7). 1574–1577. 42 indexed citations
18.
Lerner, Claude G. & Anne Y. Saiki. (1996). Scintillation Proximity Assay for Human DNA Topoisomerase I Using Recombinant Biotinyl-Fusion Protein Produced in Baculovirus-Infected Insect Cells. Analytical Biochemistry. 240(2). 185–196. 10 indexed citations
19.
Lerner, Claude G., Anne Y. Saiki, Alexander C. Mackinnon, & Xiaoling Xuei. (1996). High Throughput Screen for Inhibitors of Bacterial DNA Topoisomerase I Using the Scintillation Proximity Assay. SLAS DISCOVERY. 1(3). 135–143. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young‐Choon Moon Breakdown of academic impact, for papers by Florine Obrist Breakdown of academic impact, for papers by Isao Kinoyama Breakdown of academic impact, for papers by Taro Semba Breakdown of academic impact, for papers by Ioannis F. Voutsas Breakdown of academic impact, for papers by Carol F. Franks Breakdown of academic impact, for papers by Luis A. Carvajal Breakdown of academic impact, for papers by Chudi Ndubaku Breakdown of academic impact, for papers by Enrique Álvarez Breakdown of academic impact, for papers by Lois Resnick‐Silverman
Rankless by CCL
2026